Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Flebogamma DIF (previously Flebogammadif)

Flebogamma DIF 50 mg/ml solution for infusion · Abschnitt 4.8 · PDF-Seite 11–12

HOS-117932 · Präparat HOS-094719

- 11 -  Frequency Frequency MedDRA System Organ Adverse reaction per per Class (SOC) patient infusion Arthralgia Common Uncommon Myalgia Common Uncommon Musculoskeletal and Back pain Common Uncommon connective tissue disorders Neck pain Uncommon Rare Pain in extremity Uncommon Rare Muscle spasms Uncommon Rare Renal and urinary disorders Urinary retention Uncommon Rare Pyrexia Very Common Common Chest pain Uncommon Rare Oedema peripheral Uncommon Rare Chills Common Uncommon Rigors Common Uncommon Pain Common Uncommon Asthenia Uncommon Rare General disorders and Injection site reaction Common Uncommon administration site conditions Infusion site erythema Uncommon Rare Infusion site extravasation Uncommon Rare Injection site pruritus Uncommon Rare Infusion site inflammation Uncommon Rare Injection site swelling Uncommon Rare Injection site oedema Uncommon Rare Infusion site pain Uncommon Rare Injection site pain Uncommon Rare Blood pressure increased Uncommon Rare Blood pressure systolic increased Common Uncommon Blood pressure systolic decreased Uncommon Uncommon Investigations Body temperature increased Common Uncommon Alanine aminotransferase increased Uncommon Rare Coombs test positive Common Uncommon Injury, poisoning and Infusion related reaction Uncommon Uncommon procedural complications

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.